...
首页> 外文期刊>Oncogene >The miR-106b-25 cluster targets Smad7, activates TGF-β signaling, and induces EMT and tumor initiating cell characteristics downstream of Six1 in human breast cancer
【24h】

The miR-106b-25 cluster targets Smad7, activates TGF-β signaling, and induces EMT and tumor initiating cell characteristics downstream of Six1 in human breast cancer

机译:miR-106b-25簇靶向Smad7,激活TGF-β信号传导,并诱导人乳腺癌中Six1下游的EMT和肿瘤启动细胞特征

获取原文

摘要

The role of TGF-尾 signaling in tumorigenesis is paradoxical: it can be tumor suppressive or tumor promotional, depending on context. The metastatic regulator, Six1, was recently shown to mediate this switch, providing a novel means to explain this elusive 鈥楾GF-尾 paradox鈥? Herein, we identify a mechanism by which Six1 activates the tumor promotional arm of TGF-尾 signaling, via its ability to upregulate the miR-106b-25 microRNA cluster, and further identify a novel function for this cluster of microRNAs. Although expression of the miR-106b-25 cluster is known to overcome TGF-尾-mediated growth suppression via targeting p21 and BIM, we demonstrate for the first time that this same cluster can additionally target the inhibitory Smad7 protein, resulting in increased levels of the TGF-尾 type I receptor and downstream activation of TGF-尾 signaling. We further show that the miR-106b-25 cluster is sufficient to induce an epithelial-to-mesenchymal transition and a tumor initiating cell phenotype, and that it is required downstream of Six1 to induce these phenotypes. Finally, we demonstrate a significant correlation between miR-106b, Six1, and activated TGF-尾 signaling in human breast cancers, and further show that high levels of miR-106b and miR-93 in breast tumors significantly predicts shortened time to relapse. These findings expand the spectrum of oncogenic functions of miR-106b-25, and may provide a novel molecular explanation, through the Six1 regulated miR-106b-25 cluster, by which TGF-尾 signaling shifts from tumor suppressive to tumor promoting.
机译:TGF-β信号在肿瘤发生中的作用是自相矛盾的:根据情况的不同,它可能是抑制肿瘤的或促进肿瘤的。最近显示,转移调节剂Six1介导了这种转换,为解释这种难以捉摸的“GF-β悖论”提供了新颖的手段。在这里,我们确定一种机制,Six1通过上调miR-106b-25 microRNA簇的能力激活TGF-β信号传导的肿瘤促进臂,并进一步确定这一microRNA簇的新功能。尽管已知miR-106b-25簇的表达可通过靶向p21和BIM克服TGF-β介导的生长抑制,但我们首次证明了该簇可另外靶向抑制性Smad7蛋白,从而导致Smad7蛋白水平升高TGF-βI型受体和TGF-β信号的下游激活。我们进一步表明,miR-106b-25簇足以诱导上皮向间充质转化和肿瘤起始细胞表型,并且它是Six1下游诱导这些表型所必需的。最后,我们证明了人类乳腺癌中miR-106b,Six1和活化的TGF-β信号之间存在显着相关性,并且进一步表明,乳腺癌中高水平的miR-106b和miR-93可以显着缩短复发时间。这些发现扩展了miR-106b-25的致癌功能范围,并可能通过Six1调控的miR-106b-25簇提供了新的分子解释,通过该簇,TGF-β信号从抑制肿瘤转移到了促进肿瘤。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号